3737 — Zhongzhi Pharmaceutical Holdings Share News
0.000.00%
Last trade - 00:00- HK$604.52m
- HK$559.01m
- CNY1.74bn
Brief: Zhongzhi Pharmaceutical Expects 90% Decrease In HY Net Profit
Brief: Zhongzhi Pharmaceutical Posts HY Profit Attributable RMB83.4 Million
Brief: Zhongzhi Pharmaceutical Sees Decrease In Net Profit Of 40% For HY
Brief: Zhongzhi Pharmaceutical Declares Final Dividend Of HK3 Cents Per Share
Brief: Zhongzhi Pharmaceutical Sees Significant Increase In Net Profit For FY By More Than 50%
Brief: Zhongzhi Pharmaceutical Says HY Profit Attributable RMB134.9 Million, Increase Of 75.1%
Brief: Zhongzhi Pharmaceutical Sees Significant Increase Of Around 70% In Net Profit For HY 2023
Brief: Zhongzhi Pharmaceutical Says Shenzhen Xinmei Decoration And Construction To Provide Services
Brief: Zhongzhi Pharmaceutical Recommends Payment Of Final Dividend Of HK6 Cents Per Share
Brief: Zhongzhi Pharmaceutical Posts FY Profit Attributable RMB52.1 Million
Brief: Zhongzhi Pharmaceutical Says Cheng Jin Le Has Resigned As Exec Director
Brief: Zhongzhi Pharmaceutical Holdings Sees Profit Of Around RMB90.0 Million For Year
Brief: Zhongzhi Pharmaceutical To Allot & Issue A Total Of 23.6 Mln Subscription Shares
Brief: Zhongzhi Pharmaceutical Posts FY Profit Attributable RMB138.5 Mln Vs RMB114.7 Mln
Brief: Zhongzhi Pharmaceutical Says Lai Ying Feng Appointed As A Chief Executive In Place Of Lai Zhi Tian
Brief: Zhongzhi Pharmaceutical Says Lai Ying Sheng Appointed Chief Financial Officer
Brief: Zhongzhi Pharmaceutical Says Unit Entered Yunfu Factory Second Construction Contract
Brief: Zhongzhi Pharmaceutical Says Unit Subscribed For Wealth Management Product Of RMB80 Mln
Brief: Zhongzhi Pharmaceutical Holdings Says FY Profit Attributable RMB114.7 Mln